Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Duloxetine Long-Term Extension in Chronic Low Back Pain
NCT01914666Phase 3Completed
- Sponsor
- Eli Lilly and Company
- Start
- Sep 2013
- Primary completion
- Dec 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of duloxetine in chronic low back pain (CLBP), sponsored by Eli Lilly and Company. Primary endpoint: Number of Participants With Drug Related Adverse Events (AEs) or Any Serious AEs at Week 53. Started Sep 2013; status: completed.
02
Drugs
duloxetine
03
Conditions
chronic low back pain (CLBP)
Beyond the preview
Go deeper on NCT01914666.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01914666.